Zykadia Tablet, Film Coated
Product Images NDC 0078-0694

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Zykadia (NDC 0078-0694). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Novartis Pharmaceuticals Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

The Chemical Structure Of Ceritinib Is Ceritinib Is A White To Almost White Or Light Yellow Or Light Brown Powder With A Pka Of 9.7 And 4.1. (Zykadia 01)

FDA Label Image

Figure 1: Kaplan-meier Plot Of Progression-free Survival As Assessed By Birc By Treatment Arm In Ascend-4 (Zykadia 02)

FDA Label Image

Principal Display Panelbottle Label – 150 mgrx Only Ndc 0078-0640-70zykadia (ceritinib) Capsules 150 mg70 Capsules (Zykadia 03)

Principal Display Panelbottle Label – 150 mgrx Only		Ndc 0078-0640-70zykadia (ceritinib) Capsules 150 mg70 Capsules (Zykadia 03)
This text is a medication label for tablets containing 150mg of eritinib, with dosage information included in the prescribing information. The medication is called Zykadia and is manufactured by Novartis Pharma in Switzerland. The tablets should be stored at controlled room temperature and kept out of reach of children. This is a prescription medication and should be used as directed.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.